MARKET

CPHRF

CPHRF

Cipher Phrmctcls
OTCQX
11.08
+0.28
+2.59%
Closed 15:02 02/20 EST
OPEN
10.85
PREV CLOSE
10.80
HIGH
11.37
LOW
10.75
VOLUME
12.95K
TURNOVER
143.75K
52 WEEK HIGH
12.48
52 WEEK LOW
7.40
MARKET CAP
265.79M
P/E (TTM)
16.90
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CPHRF last week (0209-0213)?
Weekly Report · 5d ago
Weekly Report: what happened at CPHRF last week (0202-0206)?
Weekly Report · 02/09 09:28
Weekly Report: what happened at CPHRF last week (0126-0130)?
Weekly Report · 02/02 09:28
Analysts Offer Insights on Healthcare Companies: Olema Pharmaceuticals (OLMA) and Cipher Pharmaceuticals (OtherCPHRF)
TipRanks · 01/31 17:41
Cipher Wins Health Canada Review for Natroba Head Lice and Scabies Treatment
TipRanks · 01/28 14:21
Health Canada Accepts Cipher Pharmaceuticals' Natroba Submission for Review
Reuters · 01/28 13:32
CIPHER PHARMACEUTICALS ANNOUNCES HEALTH CANADA'S ACCEPTANCE FOR REVIEW OF NEW DRUG SUBMISSION FOR NATROBA™ (SPINOSAD)
Reuters · 01/28 13:30
Weekly Report: what happened at CPHRF last week (0119-0123)?
Weekly Report · 01/26 09:27
More
About CPHRF
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early-to-late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.

Webull offers Cipher Pharmaceuticals Inc stock information, including OTCQX: CPHRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPHRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPHRF stock methods without spending real money on the virtual paper trading platform.